Skip to main content
Medical information Clinical review pending

Cardiology

Partial Thromboplastin Time Activated PTT APTT Test

The Partial Thromboplastin Time Activated (PTT APTT) test evaluates your blood's clotting ability, helping to diagnose bleeding disorders and monitor anticoagulant therapy.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question
Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample
3 mL whole blood collected in a Blue Top (Sodium Citrate) tube.
Results
Confirm with the laboratory before booking.
Preparation
Overnight fasting is preferred. A duly filled Coagulation Requisition Form (Form 15) is mandatory. Confirm specific requirements with the laboratory before booking.
Test priceKSh 1,170

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the Partial Thromboplastin Time Activated PTT APTT Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

  • Insurer or scheme name & policy / member number
  • A clinician's request / prescription for the test
  • Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

+254

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

01

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

  • ✓Unexplained bruising or bleeding
  • ✓Prolonged bleeding after injury or surgery
  • ✓Family history of bleeding disorders
  • ✓Monitoring heparin therapy
  • ✓Pre-surgical assessment of clotting risk
  • ✓Suspected clotting factor deficiency
02

In plain language

What this test helps you understand

Assesses the intrinsic pathway of blood coagulation. Helps diagnose bleeding disorders like hemophilia and von Willebrand disease. Monitors anticoagulant therapy (e.g., heparin). Evaluates clotting factor deficiencies.
The Partial Thromboplastin Time Activated (PTT APTT) test is a diagnostic tool used to assess how quickly your blood clots. It measures the time it takes for a clot to form in a sample of your blood, specifically looking at the intrinsic pathway of coagulation. This pathway involves several clotting factors working together. Understanding this process is vital for identifying conditions that might cause excessive bleeding or, conversely, inappropriate clotting (thrombosis).

This test is particularly useful in diagnosing conditions like hemophilia, von Willebrand disease, and deficiencies in specific clotting factors. It also plays a crucial role in monitoring patients who are taking anticoagulant medications (blood thinners) like heparin to ensure the dosage is correct and effective.

If you have symptoms like easy bruising, prolonged bleeding from cuts, nosebleeds, or a family history of bleeding disorders, this test might be recommended. It can also be important for planning surgeries to assess clotting risks.
03

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →
04

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

1

Speak with us

We check the test and answer your questions before collection.

2

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

3

Understand your report

A counselor helps you understand the result and the next steps.

05

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →
PreparationOvernight fasting is preferred. A duly filled Coagulation Requisition Form (Form 15) is mandatory. Confirm specific requirements with the laboratory before booking.
Sample3 mL whole blood collected in a Blue Top (Sodium Citrate) tube.
MethodologyClotting time assay using automated or manual methods.
PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.
Results can be affected by various factors including medications (especially anticoagulants), liver disease, and certain medical conditions. Interpretation requires clinical correlation.
06

Read your report

What common result terms mean

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.
NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.
VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.
07

Questions people ask

Frequently asked questions

It measures the time it takes for your blood to clot, specifically assessing the intrinsic pathway of coagulation.
You might need this test if you have symptoms of bleeding disorders, are on anticoagulant medication, or are preparing for surgery.
Overnight fasting is preferred. Ensure you have the required Coagulation Requisition Form (Form 15) completed. Confirm specific instructions with the lab.
A prolonged clotting time may indicate a problem with the coagulation pathway. Your doctor will interpret the results based on your overall health.
A blood sample is drawn from a vein, typically in your arm, and collected in a specific blue-top tube.
Turnaround time varies. Please confirm the expected timeframe with the laboratory before booking.
08

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships
09

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

  • ACMG/AMP technical standards for sequence variant interpretation
  • ClinGen curation and gene–disease validity frameworks where applicable
  • LOINC-coded reporting for interoperable results
  • ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

  • Last updated: September 27, 2026
  • Medical review: not yet completed
  • Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →
Chat on WhatsApp